Table 3 Update of pre-existing diabetes quality indicators resulting from consensus process
Number of QI | Category | Subject | Nominator | Denominator |
|---|---|---|---|---|
19 | Diabetes mellitus | Proportion of insured persons below the age of 76 with antidiabetic medication without statin medication receiving control of lipid values per year | Sum of insured persons with the Pharmacy Cost Group “diabetes mellitus” below the age of 76 without statin medication for which control of lipid values was reimbursed per year | Sum of insured persons with the Pharmacy Cost Group “diabetes mellitus” below the age of 76 without statin medication per year |
20 | Diabetes mellitus | Proportion of insured persons with antidiabetic medication without ACE or AT2 inhibitors receiving control of kidney values per year | Sum of insured persons with the Pharmacy Cost Group “diabetes mellitus” without ACE or AT2 inhibitors for which control of kidney values was reimbursed per year | Sum of insured persons with the Pharmacy Cost Group “diabetes mellitus” without ACE or AT2 inhibitors per year |